“Can I tell you something?” Her voice was soft; eyes fixed on the floor.“My parents don’t like it when I’m hyper. They think I should top up my medication. Maybe there’s something wrong with me.” Her voice cracked, and tears fell silently, quick, warm, unrestrained, like summer rain.She was sixteen, bright, intense, curious, full of
Riga-based biotech innovator Cellbox Labs has secured €3.3 million in non-dilutive funding to fast-track the development of its dynamic organ-on-a-chip technology, designed to replace animal testing in drug discovery and food science. Part of the capital comes via Tech4Cure, an Important Project of Common European Interest (IPCEI) initiative supporting EU healthcare innovation and industrial resilience.
In a landmark move, the National Health Service England (NHS) has become the first health system in the world to roll out a revolutionary ‘Trojan Horse’ therapy for blood cancer. The new treatment, ‘belantamab mafodotin’, is set to transform care for people living with myeloma — an incurable form of blood cancer that affects plasma
In a landscape often dominated by urban-centric healthcare brands, Winpra Health Care Pvt. Ltd. stands out as a bold and inspiring initiative led by two dynamic young women – Managing Director Aswini C, who is also a trained pharmacist and Chairperson Prarthanaa K, an aspiring corporate leader with a background in finance. Their shared dream?
The healthcare and wellness industry is undergoing a massive transformation. We are entering an era of Wellness 2.0, shifting from a reactive, disease-management model to a proactive, integrative, and holistic approach that prioritises prevention, root-cause healing, and sustainable well-being. Consumers are no longer willing to accept short-term fixes—they want lasting solutions. Health is no longer
Akribion Therapeautics, a Zwingenberg-based BioTech startup developing a RNA-guided, nuclease-based technology for programmable cell depletion, recently announced its exit from stealth and the completion of a Seed financing round raising €8 million to accelerate the development of therapeutics based on Akribion’s proprietary G-dase® E nucleases. The round was led by CARMA FUND and RV Invest,
Berlin-based Nelly, a rising startup at the intersection of health and fintech, has secured €50 million in a Series B funding round to enter new European markets and develop new products. Led by Cathay Innovation and Notion Capital, the round also included existing investors b2venture, Lakestar, Motive Ventures, and Arc Investors. The funding positions Nelly
China describes the rise in respiratory infections as a common seasonal trend during winter despite reports of a Human Metapneumovirus (HPMV) outbreak overwhelming hospitals. Authorities maintain that the situation is less severe than last year and that there is no need for alarm regarding the virus, which is being compared to Covid-19. Despite circulating social
52North, a UK med-tech startup focused on oncological advancements, has raised €6 million in a funding round co-led by KHP Ventures and Cedars-Sinai Intellectual Property Co. The round, which also included contributions from OKG Capital, Cambridge Enterprise Ventures, Cancer Research Horizons, Macmillan Cancer Support, and angel investors like Jonathan Milner and Roland Diggelmann, brings the
More than half of the estimated 800 million adults who have diabetes are not receiving treatment for their condition, research shows. The World Health Organisation had previously estimated that about 422 million people have diabetes, a chronic disease involving blood sugar levels, which can damage the heart, blood vessels, nerves and other organs if untreated.
